Total Equity - vTv Therapeutics Inc (NASDAQ:VTVT) - Alpha Spread

vTv Therapeutics Inc
NASDAQ:VTVT

Watchlist Manager
vTv Therapeutics Inc Logo
vTv Therapeutics Inc
NASDAQ:VTVT
Watchlist
Price: 14.93 USD 6.41% Market Closed
Market Cap: 36.3m USD
Have any thoughts about
vTv Therapeutics Inc?
Write Note

vTv Therapeutics Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

vTv Therapeutics Inc
Total Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
vTv Therapeutics Inc
NASDAQ:VTVT
Total Equity
$16.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Equity
$6.8B
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Total Equity
$18.3B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
1%
Amgen Inc
NASDAQ:AMGN
Total Equity
$5.9B
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
-13%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Equity
$14.8B
CAGR 3-Years
17%
CAGR 5-Years
24%
CAGR 10-Years
29%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Equity
$28.2B
CAGR 3-Years
23%
CAGR 5-Years
24%
CAGR 10-Years
28%

See Also

What is vTv Therapeutics Inc's Total Equity?
Total Equity
16.5m USD

Based on the financial report for Jun 30, 2024, vTv Therapeutics Inc's Total Equity amounts to 16.5m USD.

Back to Top